• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经源性下尿路功能障碍:评估与管理

Neurogenic lower urinary tract dysfunction: evaluation and management.

作者信息

Tudor Katarina Ivana, Sakakibara Ryuji, Panicker Jalesh N

机构信息

Department of Neurology, University Hospital Center Zagreb, Kispaticeva 12, Zagreb, 10000, Croatia.

Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University, Sakura, Japan.

出版信息

J Neurol. 2016 Dec;263(12):2555-2564. doi: 10.1007/s00415-016-8212-2. Epub 2016 Jul 11.

DOI:10.1007/s00415-016-8212-2
PMID:27401178
Abstract

The lower urinary tract (LUT) in health is regulated by coordinated multi-level neurological inputs which require an intact central and peripheral nervous system. Lower urinary tract dysfunction is, therefore, a common sequelae of neurological disease and the patterns of bladder storage and voiding dysfunction depend upon the level of neurological lesion. Evaluation includes history taking, bladder diary, urological examination when relevant, ultrasonography and urodynamic testing when indicated. Antimuscarinic agents are the first line treatment for patients with storage dysfunction. Alternative treatments include intradetrusor injection of onabotulinumtoxinA, which has been shown to be of benefit in patients with neurogenic detrusor overactivity (NDO), and neuromodulation. Intermittent catheterization remains the option of choice in patients with significant voiding dysfunction resulting in high post-void residual volumes.

摘要

健康状态下的下尿路(LUT)受多级神经输入的协调调控,这需要完整的中枢和外周神经系统。因此,下尿路功能障碍是神经疾病的常见后遗症,膀胱储尿和排尿功能障碍的模式取决于神经损伤的程度。评估包括病史采集、膀胱日记、必要时的泌尿外科检查、超声检查以及必要时的尿动力学检测。抗毒蕈碱药物是储尿功能障碍患者的一线治疗药物。其他治疗方法包括膀胱逼尿肌内注射A型肉毒毒素,已证明其对神经源性逼尿肌过度活动(NDO)患者有益,以及神经调节。对于因排尿功能严重障碍导致大量残余尿量的患者,间歇性导尿仍是首选方法。

相似文献

1
Neurogenic lower urinary tract dysfunction: evaluation and management.神经源性下尿路功能障碍:评估与管理
J Neurol. 2016 Dec;263(12):2555-2564. doi: 10.1007/s00415-016-8212-2. Epub 2016 Jul 11.
2
Lower urinary tract dysfunction in the neurological patient: clinical assessment and management.神经系统疾病患者的下尿路功能障碍:临床评估与管理。
Lancet Neurol. 2015 Jul;14(7):720-32. doi: 10.1016/S1474-4422(15)00070-8.
3
Management and rehabilitation of neurologic patients with lower urinary tract dysfunction.下尿路功能障碍神经科患者的管理与康复
Handb Clin Neurol. 2015;130:451-68. doi: 10.1016/B978-0-444-63247-0.00026-2.
4
Neurogenic lower urinary tract dysfunction.神经源性下尿路功能障碍
Handb Clin Neurol. 2013;110:209-20. doi: 10.1016/B978-0-444-52901-5.00017-4.
5
Management of neurogenic bladder in patients with multiple sclerosis.多发性硬化症患者的神经源性膀胱管理。
Nat Rev Urol. 2016 May;13(5):275-88. doi: 10.1038/nrurol.2016.53. Epub 2016 Mar 31.
6
Lower urinary tract dysfunction in Machado-Joseph disease: a study of 11 clinical-urodynamic observations.马查多-约瑟夫病的下尿路功能障碍:11例临床尿动力学观察研究
J Neurol Sci. 2004 Mar 15;218(1-2):67-72. doi: 10.1016/j.jns.2003.11.002.
7
Lower urinary tract dysfunction in patients with multiple sclerosis.多发性硬化症患者的下尿路功能障碍
Handb Clin Neurol. 2015;130:371-81. doi: 10.1016/B978-0-444-63247-0.00021-3.
8
Neurogenic Bladder: Epidemiology, Diagnosis, and Management.神经原性膀胱:流行病学、诊断与管理。
Semin Neurol. 2020 Oct;40(5):569-579. doi: 10.1055/s-0040-1713876. Epub 2020 Oct 16.
9
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.帕金森病患者在抗毒蕈碱治疗期间出现神经源性逼尿肌过度活动,膀胱过度活动症问卷(OAB-q)与尿动力学数据之间的相关性
Clin Neuropharmacol. 2006 Jul-Aug;29(4):220-9. doi: 10.1097/01.WNF.0000228177.75711.0f.
10
Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management.康复实践:神经源性下尿路功能障碍及其管理。
Clin Rehabil. 2010 Jul;24(7):579-89. doi: 10.1177/0269215509353252.

引用本文的文献

1
Autonomic dysfunction in multiple system atrophy: from pathophysiology to clinical manifestations.多系统萎缩中的自主神经功能障碍:从病理生理学到临床表现
Ann Med. 2025 Dec;57(1):2488111. doi: 10.1080/07853890.2025.2488111. Epub 2025 Apr 8.
2
Multiple sclerosis, urinary tract infections and infertility: a comprehensive scoping review.多发性硬化症、尿路感染与不孕症:一项全面的范围综述
J Turk Ger Gynecol Assoc. 2025 Jun 10;26(2):130-141. doi: 10.4274/jtgga.galenos.2024.2024-5-2.
3
Sacral neuromodulation for Organophosphate-induced delayed neuropathy neurogenic lower urinary tract dysfunction: a case report.

本文引用的文献

1
[Not Available].[无可用内容]
Prog Urol. 2015 Nov;25(13):845-6. doi: 10.1016/j.purol.2015.08.260.
2
Anticholinergic burden is associated with recurrent and injurious falls in older individuals.抗胆碱能负担与老年人反复跌倒及跌倒致伤有关。
Maturitas. 2016 Feb;84:32-7. doi: 10.1016/j.maturitas.2015.10.009. Epub 2015 Oct 23.
3
Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome).
骶神经调控治疗有机磷诱导迟发性神经病神经原性下尿路功能障碍:病例报告。
BMC Urol. 2024 Oct 4;24(1):213. doi: 10.1186/s12894-024-01600-x.
4
Efficacy of Urethral Sphincter Botulinum Toxin A Injection in Patients with Spinal Cord Injury with Dysuria: A Retrospective Cohort Study.尿道括约肌肉毒毒素 A 注射治疗脊髓损伤后排尿困难患者的疗效:一项回顾性队列研究。
Toxins (Basel). 2024 Jul 31;16(8):336. doi: 10.3390/toxins16080336.
5
Lower urinary tract dysfunction in the central nervous system neurogenic bladder and the real-life treatment outcome of botulinum toxin A.中枢神经系统神经源性膀胱的下尿路功能障碍及A型肉毒毒素的实际治疗效果
Tzu Chi Med J. 2024 May 24;36(3):260-270. doi: 10.4103/tcmj.tcmj_29_24. eCollection 2024 Jul-Sep.
6
Skin-inspired, sensory robots for electronic implants.用于电子植入物的仿皮肤、感知机器人。
Nat Commun. 2024 Jun 5;15(1):4777. doi: 10.1038/s41467-024-48903-z.
7
Safety and efficacy of beta-3 adrenergic agonists in treating neurogenic lower urinary tract dysfunction: A systematic review and meta-analysis.β-3 肾上腺素能激动剂治疗神经原性下尿路功能障碍的安全性和有效性:系统评价和荟萃分析。
Investig Clin Urol. 2024 May;65(3):217-229. doi: 10.4111/icu.20230271.
8
Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions.肉毒杆菌毒素 A 注射治疗中枢神经系统病变患者伴膀胱过度活动症和排尿功能障碍的真实临床疗效。
Toxins (Basel). 2024 Mar 1;16(3):123. doi: 10.3390/toxins16030123.
9
A commentary on 'Efficacy of peripheral electrical nerve stimulation on improvements of urodynamics and voiding diary in patients with neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis'.对“周围神经电刺激对神经源性下尿路功能障碍患者尿动力学及排尿日记改善的疗效:一项系统评价与荟萃分析”的述评
Int J Surg. 2024 Jan 1;110(1):578-579. doi: 10.1097/JS9.0000000000000764.
10
Non-pharmacological and drug treatment of autonomic dysfunction in multiple system atrophy: current status and future directions.多系统萎缩自主神经功能障碍的非药物及药物治疗:现状与未来方向
J Neurol. 2023 Nov;270(11):5251-5273. doi: 10.1007/s00415-023-11876-y. Epub 2023 Jul 21.
开放标签研究,评估门诊患者尿道括约肌注射A型肉毒毒素治疗因括约肌松弛原发性疾病(福勒综合征)导致尿潴留的女性患者。
BJU Int. 2016 May;117(5):809-13. doi: 10.1111/bju.13342. Epub 2015 Nov 8.
4
Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology.欧洲泌尿外科学会(EAU)神经泌尿学指南摘要。
Eur Urol. 2016 Feb;69(2):324-33. doi: 10.1016/j.eururo.2015.07.071. Epub 2015 Aug 22.
5
Does anticholinergics drug burden relate to global neuro-disability outcome measures and length of hospital stay?抗胆碱能药物负担与整体神经残疾结局指标及住院时间有关吗?
Brain Inj. 2015;29(12):1426-30. doi: 10.3109/02699052.2015.1060358. Epub 2015 Aug 5.
6
Lower urinary tract dysfunction in the neurological patient: clinical assessment and management.神经系统疾病患者的下尿路功能障碍:临床评估与管理。
Lancet Neurol. 2015 Jul;14(7):720-32. doi: 10.1016/S1474-4422(15)00070-8.
7
OnabotulinumtoxinA intravesical treatment in patients affected by overactive bladder syndrome: best practice in real-life management.A型肉毒杆菌毒素膀胱内治疗膀胱过度活动症患者:现实生活管理中的最佳实践
Urologia. 2015 Jul-Sep;82(3):179-83. doi: 10.5301/uro.5000120. Epub 2015 May 20.
8
Lower urinary tract dysfunction in patients with multiple sclerosis.多发性硬化症患者的下尿路功能障碍
Handb Clin Neurol. 2015;130:371-81. doi: 10.1016/B978-0-444-63247-0.00021-3.
9
Lower urinary tract dysfunction in patients with brain lesions.脑损伤患者的下尿路功能障碍
Handb Clin Neurol. 2015;130:269-87. doi: 10.1016/B978-0-444-63247-0.00015-8.
10
Urinary considerations for adult patients with spinal dysraphism.成人脊髓脊膜膨出患者的尿液考虑因素。
Nat Rev Urol. 2015 Jun;12(6):331-9. doi: 10.1038/nrurol.2015.99. Epub 2015 May 12.